Shuttle Pharmaceuticals Holdings, Inc. Finalizes Agreements for Phase 2 Clinical Trial Enrollment: Press Release Analysis
Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation trading as SHPH on the Nasdaq Stock Market LLC, recently announced significant progress in their clinical trial endeavors. On October 28, 2024, the company issued a press release detailing the completion of agreements with all six intended site enrollment locations for the administration of the Phase 2 clinical […]
More Stories
BMO Capital Markets Has Lowered Expectations for American Tower (NYSE:AMT) Stock Price
American Tower (NYSE:AMT – Get Free Report) had its price target decreased by equities researchers at BMO Capital Markets from...
Mondelez International (NASDAQ:MDLZ) Price Target Cut to $78.00 by Analysts at Wells Fargo & Company
Mondelez International (NASDAQ:MDLZ – Get Free Report) had its price target cut by research analysts at Wells Fargo & Company...
Farmers & Merchants Investments Inc. Sells 5,500 Shares of AT&T Inc. (NYSE:T)
Farmers & Merchants Investments Inc. cut its holdings in shares of AT&T Inc. (NYSE:T – Free Report) by 6.4% during...
Barclays Issues Positive Forecast for Unum Group (NYSE:UNM) Stock Price
Unum Group (NYSE:UNM – Get Free Report) had its price target raised by equities research analysts at Barclays from $72.00...
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Reduces Stock Position in The Procter & Gamble Company (NYSE:PG)
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA decreased its holdings in The Procter & Gamble Company (NYSE:PG – Free...
DeepOnion (ONION) Price Hits $0.0215
DeepOnion (ONION) traded 1.2% lower against the dollar during the 1 day period ending at 14:00 PM Eastern on October...